Given that the most dangerous toxins are those that are closest to us, it stands to reason that the toxins in our body may be the most dangerous of all. We can’t avoid the fact that we live in a polluted world. Every day we are exposed to toxic heavy metals such as lead and cadmium in the air we breathe, the water we drink, and the food we eat.
Intellectual Medicine offers the following testing
We measure the following 132 foods and additives including candida. Find out which you are sensitive to and start a new way of living.
This test is a patented, multi-pathway delayed food sensitivity test. The test uses new technology that measures both IgG and Immune Complexes, the most common food-related pathways in the body. A simple blood test is needed.
Our micronutrient test measures 31 vitamins, minerals, amino/fatty acids, antioxidants, and metabolites – and how they affect cellular function in person. Correlating micronutrient deficiencies not only slows aging and degenerative disease progression, but it can also prevent as well as repair cellular dysfunction, and by extension, disease.
For Lyme and Co-infections
Lyme disease and other co-infections can be incredibly hard to diagnose. In some cases, conventional testing can be negative, even when Lyme Disease or other co-infections are present.
For individuals facing uncertainty in diagnosis, the “Vibrant“ reference laboratory test can offer a more sensitive means of testing. There have been cases where the Vibrant test was positive, when conventional testing was negative. This can help to direct proper care.
The role of toxic heavy metals in disease states has been widely neglected by conventional medicine.
Lead is known to contribute to high blood pressure, heart disease, brain damage and dementia. Cadmium, nickel, and arsenic are known carcinogens. Aluminum increases the risk of dementia and other neurological disorders. Gadolinium once thought to be a harmless contrast material for MRI studies, has recently been shown to accumulate in the brain.
The IvyGene test is a more sensitive means of evaluating for the presence of cancer somewhere in the body. It looks for A specific pattern of methylated DNA that is unique to cancer cells. Methylated DNA is easier to detect in the blood and circulating tumor cells, therefore this test may be more sensitive.
It is currently approved for testing breast, colon, liver and lung cancer.
This test has not been approved as a screening tool for people without cancer. It is used to monitor people who have a history of cancer, or people who are actively being treated for cancer.
Liquid biopsies are typically conducted with blood as the sample type and are used to identify cancer biomarkers in circulating tumor DNA (ctDNA) or on circulating tumor cells (CTCs), which are the most commonly evaluated indicators or drivers of cancer development. Doctors may use liquid biopsies to help design cancer treatment plans, to evaluate how well treatment is working, or to determine if a prior cancer condition has recurred. The ability to take multiple samples of blood may help doctors understand what kind of molecular changes are taking place over time in a patient’s tumor.
Biocept offers a series of “blood biopsies “that can be used to detect the presence of circulating tumor cells. This test is appropriate for individuals who have had cancer or are currently being treated for cancer. Identifying the amount of circulating tumor cells, complementary treatments can be aligned with conventional therapy to attempt to reduce the risk of cancer progression or relapse.
This test is not approved as a screening tool for cancer and does not replace conventional monitoring techniques for malignancy.
Since many of the tests that we run require that the blood is drawn in a specific manner, we offer phlebotomy service at the Intellectual Medicine. Your blood will be drawn in the comfortable environment and all the proper steps will be taken to make sure it is properly delivered to the lab.